Oorsprong van het eerstegraads netwerk van Sahani Chandraratna
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Io Therapeutics, Inc. develops retinoid and rexinoid molecule drugs for the treatment of cancer. The company is based in Spring, TX. The company was founded by Martin E. Sanders, Rosh Chandraratna. Martin E. Sanders has been the CEO since incorporation.
2
| Holding Company | Biotechnology | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Sahani Chandraratna via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
The University of Chicago | College/University | Doctorate Degree | |
DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Corporate Officer/Principal | |
University of Missouri | College/University | Undergraduate Degree | |
Palingen, Inc. (US) | President | ||
Seurat Therapeutics, Inc.
Seurat Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Seurat Therapeutics, Inc. engages in the provision of migraine medication. It develops a nasal sprat to alleviate and prevent migraine. The company was founded by Martin E. Sanders, Yuan Zhang, and Richard Kraig and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Founder | |
ACUCELA INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistieken
Internationaal
Verenigde Staten | 10 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 5 |
Founder | 3 |
President | 2 |
Director/Board Member | 2 |
Doctorate Degree | 1 |
Sterkste connecties
Insiders | |
---|---|
Martin E. Sanders | 6 |
Rosh Chandraratna | 5 |
- Beurs
- Insiders
- Sahani Chandraratna
- Bedrijfsconnecties